Back
Nuvalent, Inc. Vs. BioXcel Therapeutics, Inc. Industry Stock Comparison
Sell
41
NUVL
Nuvalent, Inc.
Last Price:
$100.16
Seasonality Move:
-11.13%
Sell
19
BTAI
BioXcel Therapeutics, Inc.
Last Price:
$1.53
Seasonality Move:
59.54%
Sell
41
Nuvalent, Inc. (NUVL)
is a Sell
Is Nuvalent, Inc. a Buy, Sell or Hold?
-
The current Nuvalent, Inc. [NUVL] share price is $101.76. The Score for NUVL is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
NUVL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
BioXcel Therapeutics, Inc. (BTAI)
is a Sell
Is BioXcel Therapeutics, Inc. a Buy, Sell or Hold?
-
The current BioXcel Therapeutics, Inc. [BTAI] share price is $1.56. The Score for BTAI is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
BTAI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
NUVL Stock Price Chart
What is Nuvalent, Inc.'s stock price today?
-
The Nuvalent, Inc. share price today is $101.76Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NUVL is experiencing selling pressure, which indicates risk of future bearish movement.
BTAI Stock Price Chart
What is BioXcel Therapeutics, Inc.'s stock price today?
-
The BioXcel Therapeutics, Inc. share price today is $1.56Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing selling pressure, which indicates risk of future bearish movement.
NUVL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.46 | Buy |
| Relative Strength Index (14 RSI): | 45.86 | Sell |
| Chaikin Money Flow: | -130269 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (103.29 - 108.23) | Sell |
| Bollinger Bands (100): | (78.64 - 102.74) | Buy |
BTAI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 33.51 | Sell |
| Chaikin Money Flow: | -502263 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.75 - 2.11) | Sell |
| Bollinger Bands (100): | (1.64 - 4) | Sell |
NUVL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 103.58 | Sell |
| 20-day SMA: | 105.02 | Sell |
| 50-day SMA: | 101.53 | Buy |
| 200-day SMA: | 83.07 | Buy |
| 8-day EMA: | 103.89 | Sell |
| 20-day EMA: | 104.13 | Sell |
| 50-day EMA: | 100.42 | Buy |
| 200-day EMA: | 88.17 | Buy |
BTAI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.74 | Sell |
| 20-day SMA: | 1.93 | Sell |
| 50-day SMA: | 1.97 | Sell |
| 200-day SMA: | 2.3 | Sell |
| 8-day EMA: | 1.73 | Sell |
| 20-day EMA: | 1.85 | Sell |
| 50-day EMA: | 2.06 | Sell |
| 200-day EMA: | 4.42 | Sell |
Nuvalent, Inc. Earnings Growth & NUVL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.00 per share.
BioXcel Therapeutics, Inc. Earnings Growth & BTAI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.68 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.74 per share, and a decrease next year of $0.00 per share.
Nuvalent, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioXcel Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||